Arch Biopartners Inc. Stock Toronto S.E.
Equities
ARCH
CA03938C1041
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 CAD | -0.92% |
|
-2.42% | +8.78% |
Jun. 27 | Arch Biopartners Up More Than 2% After Announcing GMP Manufacturing Of Cilastatin Drug Product | MT |
Jun. 27 | Arch Biopartners Inc. Announces GMP Manufacturing of Cilastatin Drug Product | CI |
Sales 2024 * | 2M 1.46M | Sales 2025 * | 2M 1.46M | Capitalization | 104M 76.36M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 52.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 52.2 x |
P/E ratio 2024 * |
-23.2
x | P/E ratio 2025 * |
-23.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.82% |
1 day | -0.92% | ||
1 week | -2.42% | ||
Current month | -4.17% | ||
1 month | -4.73% | ||
3 months | -31.49% | ||
6 months | +5.23% | ||
Current year | +8.78% |
![Extreme 1.6](/images/extremecours_fleche.png)
![Extreme 1.6](/images/extremecours_fleche.png)
![Extreme 1.37](/images/extremecours_fleche.png)
![Extreme 0.97](/images/extremecours_fleche.png)
![Extreme 0.97](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Daniel Muruve
FOU | Founder | - | 83-03-03 |
Richard Muruve
FOU | Founder | - | 83-03-03 |
Andrew Bishop
DFI | Director of Finance/CFO | 58 | 10-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rossman
BRD | Director/Board Member | - | 10-05-06 |
Richard Muruve
FOU | Founder | - | 83-03-03 |
Claude Allary
BRD | Director/Board Member | 69 | 14-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-16 | 1.61 | -0.92% | 1,700 |
24-07-15 | 1.625 | +0.31% | 4,200 |
24-07-12 | 1.62 | -0.92% | 2,565 |
24-07-11 | 1.635 | -1.51% | 34,900 |
24-07-10 | 1.66 | +0.61% | 10,498 |
Delayed Quote Toronto S.E., July 16, 2024 at 03:59 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- ACHFF Stock
- ARCH Stock